UY28375A1 - Agente terapéuticos - Google Patents

Agente terapéuticos

Info

Publication number
UY28375A1
UY28375A1 UY28375A UY28375A UY28375A1 UY 28375 A1 UY28375 A1 UY 28375A1 UY 28375 A UY28375 A UY 28375A UY 28375 A UY28375 A UY 28375A UY 28375 A1 UY28375 A1 UY 28375A1
Authority
UY
Uruguay
Prior art keywords
hexyl
ethoxy
amino
propanoic acid
phenylethyl
Prior art date
Application number
UY28375A
Other languages
English (en)
Inventor
Aurell Carl-Johan
Minidis Anna
Starle Erica
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY28375A1 publication Critical patent/UY28375A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/18—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides
    • C07C235/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the singly-bound oxygen atoms further bound to a carbon atom of a six-membered aromatic ring, e.g. phenoxyacetamides having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Compuesto que comprende una sal seleccionada de los siguientes puntos:-(1R,2S)-2-hidroxiindan-1-amina de ácido (2S)-2-etoxi-3-(4-(2-(hexil(2-feniletil)amino)-2- oxoetoxi)fenil) propanoico; -L-arginina de ácido (2S)-2-etoxi-3-(4-(2-(hexil(2-feniletil)amino-2-oxoetoxifenil)propanoico; -ter-butilamina de ácido (2S)-2-etoxi-3-(4-(2-(hexil(2-feniletil)amino-2-oxoetoxifenil)propanoico; -colina de ácido (2S)-2-etoxi-3-(4-(2-(hexil(2-feniletil)amino)-2-oxoetoxi)fenil)propanoico; -adamantilamina de ácido (2S)-2-etoxi-3-(4-(2-(hexil(2-feniletil)amino-2.oxotoxifenil) propanoico; -bencil-2-feniletaminio de ácido (2S)-2-etoxi-3-(4-(2-(hexil(2-feniletil)amino-2-oxoetoxifenil)propanoico; -N-bencil-2-(bencilamino)etanaminio de ácido (2S)-2-etoxi-3-(4-(2-(hexil(2-femiletil)amino-2-oxoetoxitenil) propanoico; -tris (hidroximetil) metilamina de ácido (2S) -2-etoxi-3.(4-(2-(hexil(2-femiletil)amino)-2-oxoetoxi)fenil)propanoico.
UY28375A 2003-06-18 2004-06-18 Agente terapéuticos UY28375A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0314129.8A GB0314129D0 (en) 2003-06-18 2003-06-18 Therapeutic agents

Publications (1)

Publication Number Publication Date
UY28375A1 true UY28375A1 (es) 2005-01-31

Family

ID=27636788

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28375A UY28375A1 (es) 2003-06-18 2004-06-18 Agente terapéuticos

Country Status (23)

Country Link
US (1) US20060142389A1 (es)
EP (1) EP1638922A1 (es)
JP (1) JP3822900B1 (es)
KR (1) KR20060027348A (es)
CN (1) CN1809529A (es)
AR (1) AR044801A1 (es)
AU (1) AU2004247610B2 (es)
BR (1) BRPI0411525A (es)
CA (1) CA2528932A1 (es)
CO (1) CO5650228A2 (es)
GB (1) GB0314129D0 (es)
IL (1) IL172167A0 (es)
IS (1) IS8231A (es)
MX (1) MXPA05013714A (es)
MY (1) MY137277A (es)
NO (1) NO20055922L (es)
RU (1) RU2005138590A (es)
SA (1) SA04250169B1 (es)
TW (1) TW200503677A (es)
UA (1) UA81807C2 (es)
UY (1) UY28375A1 (es)
WO (1) WO2004110984A1 (es)
ZA (1) ZA200510252B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0104333D0 (sv) 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
GB0314079D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0229931D0 (en) * 2002-12-21 2003-01-29 Astrazeneca Ab Therapeutic agents
SE0104334D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents
DK1517883T3 (da) 2002-06-20 2008-05-26 Astrazeneca Ab Ortho-substituerede benzoesyrederivater til behandling af insulinresistens
SE0403072D0 (sv) * 2004-12-16 2004-12-16 Astrazeneca Ab Pharmaceutically useful salts of carboxylic acid derivates
WO2007004957A1 (en) * 2005-07-05 2007-01-11 Astrazeneca Ab Novel crystalline form
AR055073A1 (es) * 2005-07-11 2007-08-01 Astrazeneca Ab Agentes terapeuticos
MX2013014310A (es) * 2011-06-06 2014-01-23 Akebia Therapeutics Inc Compuestos y composiciones para estabilizar el factor-2 alfa inducible por hipoxia como un metodo para tratar el cancer.
NO2686520T3 (es) 2011-06-06 2018-03-17
NZ753905A (en) 2013-06-13 2020-07-31 Akebia Therapeutics Inc Compositions and methods for treating anemia
TWI788702B (zh) 2013-11-15 2023-01-01 美商阿克比治療有限公司 {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式，其組合物及用途
AU2016209126A1 (en) 2015-01-23 2017-08-10 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
US11324734B2 (en) 2015-04-01 2022-05-10 Akebia Therapeutics, Inc. Compositions and methods for treating anemia
US11713298B2 (en) 2018-05-09 2023-08-01 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2219172C2 (ru) * 1999-04-06 2003-12-20 Санкио Компани, Лимитед α-ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ КАРБОНОВЫХ КИСЛОТ
SE0104334D0 (sv) * 2001-12-19 2001-12-19 Astrazeneca Ab Therapeutic agents

Also Published As

Publication number Publication date
RU2005138590A (ru) 2006-07-27
CO5650228A2 (es) 2006-06-30
US20060142389A1 (en) 2006-06-29
WO2004110984A1 (en) 2004-12-23
SA04250169B1 (ar) 2007-08-07
NO20055922L (no) 2006-01-06
IS8231A (is) 2006-01-13
CN1809529A (zh) 2006-07-26
TW200503677A (en) 2005-02-01
IL172167A0 (en) 2009-02-11
BRPI0411525A (pt) 2006-08-01
UA81807C2 (uk) 2008-02-11
GB0314129D0 (en) 2003-07-23
MXPA05013714A (es) 2006-06-27
MY137277A (en) 2009-01-30
AR044801A1 (es) 2005-10-05
ZA200510252B (en) 2006-12-27
KR20060027348A (ko) 2006-03-27
EP1638922A1 (en) 2006-03-29
JP3822900B1 (ja) 2006-09-20
AU2004247610A1 (en) 2004-12-23
CA2528932A1 (en) 2004-12-23
AU2004247610B2 (en) 2008-04-17
JP2006527766A (ja) 2006-12-07
SA04250169A (ar) 2005-12-03

Similar Documents

Publication Publication Date Title
UY28375A1 (es) Agente terapéuticos
AR109423A2 (es) Sal moduladora de la vía hedgehog
DK1814534T3 (da) Derivater af 5-aminolevulinsyre til behandling af acne
CY1118428T1 (el) Ζιζανιοκτονα σκευασματα γλυφοσατης υψηλης ισχυος και χαμηλου ιξωδους
CR8278A (es) Combinaciones sinergicas de productos activos, fungicidas
RU2010145459A (ru) Ингибиторы активности протеинтирозинкиназы
NO20052884D0 (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
RS52274B (en) UNIT DIARYLHIDANTOIN
AR028499A1 (es) Sintesis asimetrica de pregabalin
DK1651621T3 (da) 2-(Quinoxalin-5-ylsulfonylamino)benzamidforbindelser som CCK2-modulatorer
DK1694318T3 (da) (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
AR053554A1 (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
RS52681B (en) HYDROBENZOATE SALTS OF METHANICOTINE COMPOUND
CY1108334T1 (el) Υποκατασταθεισες δικετοπιπεραζινες ως ανταγωνιστες ωκυτοκινης
EA200702039A1 (ru) 7-аминоалкилиденилгетероциклические хинолоны и нафтиридоны
RS52108B (en) 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS
EA200600760A1 (ru) Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их
EA200801215A1 (ru) Применение пираклостробина в качестве сафенера для тритиконазола при борьбе с вредными грибами
AR036581A1 (es) Composicion herbicida
CO5580725A2 (es) Herbicidas selectivos a base de tien-3-ilsulfonilamino (tio)-carbonil-triazolin(tio)onas substituidas y protectores
UY28371A1 (es) Agentes terapéuticos
EA200500204A1 (ru) Новый способ синтеза (7-метокси-1-нафтил)ацетонитрила и его применение при синтезе агомелатина
CY1111881T1 (el) Υδατικη φαρμακοτεχνικη μορφη του 4-[((4-καρβοξυβουτυλο)-{2-[(4-φαιναιθυλο-βενζυλο)οξυ]φαιναιθυλο}-αμινο)μεθυλο]βενζοϊκου οξεος
DK1301475T3 (da) Arylsulfonamider, som serotoninantagonist til behandling af obesitet
AR027754A1 (es) Nuevo procedimiento para la sintesis de esteres de n-[(s)-1-carboxibutil]-(s)-alanina y aplicacion en la sintesis de perindopril

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20150611